Pharmacology

Kareus Therapeutics SA has announced the start of a Phase I clinical study following the Investigational New Drug (IND) approval from the US Food and Drug Administration for the development of KU-046…

Dipexium Pharmaceuticals, LLC today announced that it has reached an agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment for an upcoming Phase 3 registration trial…

Merck Serono, a division of Germany's Merck, announced that the U.S. Food and Drug Administration (FDA) approved Rebif(R) Rebidose(R) (interferon beta-1a), a single-use auto-injector for the self-…

The ability to accurately recall the shapes and spatial relationships of objects has been shown to be reduced by long-term use of anabolic-androgenic steroids (AAS), according to a recent paper.…

Jazz Pharmaceuticals plc announced that data from the largest safety trial to date of patients treated with Erwinaze® (asparaginase Erwinia chrysanthemi) based on results of a compassionate use…

A survey published in Archives of Pediatrics&Adolescent Medicine  finds that 14.2 percent of teenage children with any mental disorder have been treated with a psychotropic medication in the…

A previously invincible mutation in chronic myeloid leukemia (CML) has been thwarted by an investigational drug in a phase I clinical trial. 12 patients in a trial with chronic phase CML and the…

Merck Serono, a division of Merck, has donated its 100 millionth praziquantel tablet to the World Health Organization (WHO). Schistosomiasis is the second-most prevalent tropical disease in Africa…

The European Commission has approved  Abbott's HUMIRA® (adalimumab) for the treatment of pediatric patients aged 6 to 17 years with severe active Crohn's disease (CD) who failed, are intolerant…

A new substance class for the treatment of multiple sclerosis and other neurodegenerative diseases now promises increased efficacy paired with fewer side effects. To achieve this, a team of…